| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 8.476 | 17.564 | 16.539 | 10.454 | 9.667 | 16.799 | 15.474 | 16.134 | 23.137 |
| Total Income - EUR | - | 8.476 | 17.566 | 16.539 | 10.454 | 20.181 | 16.799 | 15.474 | 16.134 | 23.176 |
| Total Expenses - EUR | - | 4.475 | 14.804 | 13.524 | 12.142 | 21.757 | 18.969 | 16.785 | 15.451 | 11.785 |
| Gross Profit/Loss - EUR | - | 4.001 | 2.762 | 3.015 | -1.688 | -1.576 | -2.171 | -1.311 | 682 | 11.392 |
| Net Profit/Loss - EUR | - | 3.747 | 1.867 | 2.519 | -2.001 | -2.137 | -2.665 | -1.775 | -641 | 8.885 |
| Employees | - | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Belc Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 18.271 | 12.417 | 6.765 | 32.454 | 22.214 | 12.733 | 3.174 | 0 |
| Current Assets | - | 4.060 | 1.224 | 2.058 | 1.290 | 1.571 | 2.726 | 1.452 | 2.255 | 8.632 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 325 | 241 | 1.074 | 1.264 | 1.240 | 1.213 | 203 | 556 | 3.619 |
| Cash | - | 3.736 | 984 | 983 | 25 | 331 | 1.513 | 1.249 | 1.699 | 5.014 |
| Shareholders Funds | - | 3.792 | 5.594 | 8.011 | 5.854 | 3.607 | 862 | -910 | -1.549 | 7.345 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 269 | 13.901 | 6.464 | 2.200 | 30.418 | 24.077 | 15.095 | 6.977 | 1.287 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Belc Medical Srl